Cartalax
CARTShort peptide bioregulator studied in connective tissue.
Also known as: AED peptide bioregulator
Overview
Cartalax is a short peptide bioregulator studied in connective-tissue and anti-inflammatory research, part of the Khavinson short-peptide family.
A short peptide bioregulator (tripeptide) studied for cartilage and connective-tissue-specific signaling. Like other bioregulators, it is proposed to act at very low amounts to normalize tissue-specific gene expression over short repeatable courses.
Studied for penetrating cells and modulating gene expression related to connective-tissue regulation and inflammation.
Molecular information
Ala-Glu-AspPart of the short-peptide bioregulator family targeting cartilage/connective tissue.
Pharmacokinetics
Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.
Research applications
- Connective-tissue research
- Anti-inflammatory studies
- Peptide-bioregulator investigations
Research protocols
Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.
Observed effects timeline
Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.
Course (10–20 days)
Bioregulator protocols emphasize short, repeatable courses rather than continuous use.
Between courses
Connective-tissue effects are proposed to persist via gene-regulatory normalization.
Research compatibility
Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.
Epitalon
Complementary bioregulators; frequently used in sequence.
Pinealon
Different target tissue; complementary in protocols.
Prostamax
Different target tissue; complementary bioregulator.
How to reconstitute
Reconstitute with bacteriostatic water, swirl gently, and refrigerate. Short peptides are sensitive to heat and agitation.
- 1Allow the vial to reach room temperature (15–20 minutes).
- 2Swab the stopper with alcohol and let it air dry.
- 3Add bacteriostatic water slowly down the vial wall.
- 4Swirl gently until dissolved into a clear solution.
- 5Refrigerate at 2–8 °C and protect from light.
Quality indicators
Uniform white powder
Lyophilized cake should be white to off-white without discoloration.
Clear solution
Reconstitutes to a clear, colorless, particle-free solution.
Slight clumping
Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.
Collapsed or melted appearance
Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.
Cloudy after reconstitution
Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.
Reported observations & safety
Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.
- Generally reported as well tolerated in the bioregulator literature, which is largely from a single research lineage.
- Independent replication outside the originating group is limited.
References & further reading
Short peptide bioregulators in connective tissue (review)
Review of the short-peptide bioregulator concept and proposed cartilage/connective-tissue signaling.
View studyTopics
This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.
Active but early-stage research; evidence still developing.
This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.
Browse catalogue